Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 1925 to 1974 of 6456 in total 
Value Type: Measured
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Network Comparison Type\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
963\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
annexin a11 (annexin xi) (calcyclin-associated annexin 50) (cap-50) (56 kda autoantigen). [source:swissprot;acc:p50995]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5778.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6328.56\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
549.91\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
cytochrome c oxidase subunit iv isoform 1, mitochondrial precursor (ec 1.9.3.1) (cox iv-1) (cytochrome c oxidase polypeptide iv). [source:swissprot;acc:p13073]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
11773\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
10733.2\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.09688\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
964\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytochrome c oxidase subunit iv isoform 2, mitochondrial precursor (ec 1.9.3.1) (cox iv-2). [source:swissprot;acc:q96kj9]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
synapsin iii. [source:swissprot;acc:o14994]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5791.82\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
6340.86\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
549.04\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
965\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
aspartate beta-hydroxylase isoform b; junctin isoform 1; junctate; aspartyl/asparaginyl-beta-hydroxylase; peptide-aspartate beta-dioxygenase; humbug. [source:refseq;acc:nm\_032468]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein kinase c, eta type (ec 2.7.1.-) (npkc-eta) (pkc-l). [source:swissprot;acc:p24723]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
11773.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10733.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09688\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
966\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
galectin-4 (lactose-binding lectin 4) (l-36 lactose binding protein) (l36lbp) (antigen ny-co-27). [source:swissprot;acc:p56470]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
7817.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8575.12\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09686\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
hairy/enhancer-of-split related with yrpw motif 1 (hairy and enhancer of split related-1) (hesr-1) (cardiovascular helix-loop-helix factor 2) (hes-related repressor protein 2 herp2). [source:swissprot;acc:q9y5j3]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5791.82\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
6340.86\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
549.04\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
967\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
actin binding lim protein 2. [source:refseq;acc:nm\_032432]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein 4.1 (band 4.1) (p4.1) (epb4.1) (4.1r). [source:swissprot;acc:p11171]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7813.35\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8569.96\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09684\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
968\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
hairy/enhancer-of-split related with yrpw motif-like. [source:refseq;acc:nm\_014571]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5791.82\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6340.86\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
549.04\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
spectrin beta chain, brain 4 (spectrin, non-erythroid beta chain 4) (beta-v spectrin) (bspecv). [source:swissprot;acc:q9nrc6]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
7813.48\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8570.11\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.09684\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
969\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
band 4.1-like protein 1 (neuronal protein 4.1) (4.1n). [source:swissprot;acc:q9h4g0]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
7813.34\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8569.95\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
synapsin ii. [source:swissprot;acc:q92777]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5791.82\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6340.86\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
549.04\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
970\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
band 4.1-like protein 3 (4.1b) (differentially expressed in adenocarcinoma of the lung protein 1) (dal-1). [source:swissprot;acc:q9y2j2]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7813.45\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8570.07\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09684\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
mitochondrial ribosome recycling factor. [source:refseq;acc:nm\_138777]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5791.82\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6340.86\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
549.04\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
971\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
band 4.1-like protein 2 (generally expressed protein 4.1) (4.1g). [source:swissprot;acc:o43491]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7813.36\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8569.97\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09684\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
peroxisomal targeting signal 1 receptor (peroxismore receptor 1) (peroxisomal c-terminal targeting signal import receptor) (pts1-bp) (peroxin-5) (pts1 receptor). [source:swissprot;acc:p50542]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5791.82\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6340.86\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
549.04\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
972\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
45 kda calcium-binding protein precursor (cab45) (stromal cell-derived factor 4) (sdf-4). [source:swissprot;acc:q9brk5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7813.48\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8570.11\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09684\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
hairy/enhancer-of-split related with yrpw motif 2; gridlock; hes-related repressor protein 1. [source:refseq;acc:nm\_012259]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5791.82\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6340.86\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
549.04\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
973\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
galectin-9 (hom-hd-21) (ecalectin). [source:swissprot;acc:o00182]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7810.11\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8566.29\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09682\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor hes-1 (hairy and enhancer of split 1) (hairy- like) (hhl) (hairy homolog). [source:swissprot;acc:q14469]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5791.82\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
6340.86\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
549.04\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
974\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
delta3,5-delta2,4-dienoyl-coa isomerase, mitochondrial precursor (ec 5.3.3.-). [source:swissprot;acc:q13011]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
dimethylaniline monooxygenase [n-oxide forming] 2 (ec 1.14.13.8) (pulmonary flavin-containing monooxygenase 2) (fmo 2) (dimethylaniline oxidase 2) (fmo 1b1). [source:swissprot;acc:q99518]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5365.06\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5884.52\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09682\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
975\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
actin-binding lim protein 1 isoform a; lim actin-binding protein 1; limatin; actin-binding lim protein. [source:refseq;acc:nm\_002313]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5791.82\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6340.86\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
549.04\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
dimethylaniline monooxygenase [n-oxide forming] 1 (ec 1.14.13.8) (fetal hepatic flavin-containing monooxygenase 1) (fmo 1) (dimethylaniline oxidase 1). [source:swissprot;acc:q01740]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
5365.14\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5884.43\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09679\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
976\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dimethylaniline monooxygenase [n-oxide forming] 4 (ec 1.14.13.8) (hepatic flavin-containing monooxygenase 4) (fmo 4) (dimethylaniline oxidase 4). [source:swissprot;acc:p31512]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
5365.22\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5884.32\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09675\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
synapsin i (brain protein 4.1). [source:swissprot;acc:p17600]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
5791.82\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6340.86\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
549.04\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
977\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
annexin a7 (annexin vii) (synexin). [source:swissprot;acc:p20073]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
5780.34\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6329.3\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
548.96\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
u3 small nucleolar ribonucleoprotein protein mpp10 (m phase phosphoprotein 10). [source:swissprot;acc:o00566]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4115.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4513.14\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09651\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
978\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
lymphoid enhancer binding factor 1 (lef-1) (t cell-specific transcription factor 1-alpha) (tcf1-alpha). [source:swissprot;acc:q9uju2]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5385.04\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5933.65\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
548.61\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
vesicle-associated membrane protein 2 (vamp-2) (synaptobrevin 2). [source:swissprot;acc:p19065]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6654.42\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7296.51\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09649\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
979\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor dp-1 (e2f dimerization partner 1) (drtf1- polypeptide-1) (drtf1). [source:swissprot;acc:q14186]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3890.53\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4439.07\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
548.54\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
vesicle-associated membrane protein 1 (vamp-1) (synaptobrevin 1). [source:swissprot;acc:p23763]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6654.42\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7296.51\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09649\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
980\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
similar to lim domain only 7 (fragment). [source:sptrembl;acc:q8n6m2]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5887.52\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6434.32\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
546.8\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
vesicule-associated membrane protein 4 (vamp-4). [source:swissprot;acc:o75379]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6654.42\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
7296.51\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.09649\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
981\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cdp-diacylglycerol--inositol 3-phosphatidyltransferase (ec 2.7.8.11) (phosphatidylinositol synthase) (ptdins synthase) (pi synthase). [source:swissprot;acc:o14735]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
loh1cr12. [source:refseq;acc:nm\_058169]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5195.48\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5741.63\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
546.15\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
982\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
adp-ribosylation factor gtpase activating protein 1 (adp-ribosylation factor 1 gtpase activating protein) (arf1 gap) (arf1-directed gtpase- activating protein) (gap protein). [source:swissprot;acc:q8n6t3]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6654.42\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7296.51\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09649\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
unr protein. [source:swissprot;acc:o75534]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
5195.48\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5741.63\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
546.15\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
983\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
tryptophan 2,3-dioxygenase (ec 1.13.11.11) (tryptophan pyrrolase) (tryptophanase) (tryptophan oxygenase) (tryptamin 2,3-dioxygenase) (trpo). [source:swissprot;acc:p48775]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
5350.87\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5896.82\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
545.95\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
vesicle-associated membrane protein 3 (vamp-3) (synaptobrevin 3) (cellubrevin) (ceb). [source:swissprot;acc:q15836]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6654.42\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7296.51\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09649\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
984\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
adenosylhomocysteinase (ec 3.3.1.1) (s-adenosyl-l-homocysteine hydrolase) (adohcyase). [source:swissprot;acc:p23526]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5568.96\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6113.35\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
544.39\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
integral membrane protein 2b (transmembrane protein bri) [contains: abri/adan amyloid peptide]. [source:swissprot;acc:q9y287]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6362.64\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6976.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09642\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
985\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
atp-dependent rna helicase ddx18 (dead-box protein 18) (myc-regulated dead-box protein) (mrdb). [source:swissprot;acc:q9nvp1]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3720.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4264.46\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
544.28\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
integral membrane protein 2c (transmembrane protein bri3) (npd018). [source:swissprot;acc:q9nqx7]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6362.64\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6976.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09642\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
986\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
26s proteasome non-atpase regulatory subunit 2 (26s proteasome regulatory subunit s2) (26s proteasome subunit p97) (tumor necrosis factor type 1 receptor associated protein 2) (55.11 protein). [source:swissprot;acc:q13200]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6436.19\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6980.13\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
543.94\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
integral membrane protein 2a (e25 protein). [source:swissprot;acc:o43736]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6362.64\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6976.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09642\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
987\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
maguk p55 subfamily member 3 (mpp3 protein) (discs, large homolog 3). [source:swissprot;acc:q13368]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6660.04\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7301.81\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09636\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
tubulin-tyrosine ligase. [source:refseq;acc:nm\_153712]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5511.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6054.71\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
543.51\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/